BACKGROUND Acute pharmacologic treatments for migraine are often switched in clinical practice. Switch studies have typically focused on treatment effects.
A previous analysis of the AMPP study found that 91.7% of respondents with migraine used acute treatments for headache. Of these respondents18.3% used.
Resource Allocation in Translational Neuroscience: An Industry Perspective in 2009 Janet Vergis President Janssen, McNeil Pediatrics, and Ortho-McNeil.
BACKGROUND
